Baymatob's flagship product, Oli, is currently under development and not yet commercially available. Baymatob works closely with clinical experts to ensure Oli is created in line with their expectations and goals and facilitate adoption after relevant regulatory approvals are secured.
Baymatob also has worked with and continues to work with leading hospitals in Australia and around the world on clinical studies to receive a breadth of insights and feedback.
Baymatob's in-house AI/ML expertise is utilised not only for product development but also to upskill new team members and build Australian capability in this field.
Website
Disclaimer
Any information included herewith is in no way an endorsement of the listed organisations by the National Artificial Intelligence Centre or CSIRO.